Abstract
Carriers of hepatitis B virus (HBV) who require allogeneic hematopoietic stem cell transplantation are at increased risk of hepatic morbidity and mortality. We report the course of a 12-year-old female hepatitis B surface antigen (HBsAg)- and hepatitis B envelope antigen (HBeAg)-positive HBV carrier with acute lymphoblastic leukemia who cleared HBV after successful allogeneic blood stem cell transplantation from an anti-hepatitis B surface antibody- and anti-hepatitis B core antibody-positive, HLA-identical sibling and preemptive antiviral therapy with lamivudine. This case demonstrates that durable clearance of longstanding HBV infection can be safely achieved by antiviral chemotherapy and adoptive immunity transfer from a naturally immune matched related donor.
| Original language | English |
|---|---|
| Pages (from-to) | 753-755 |
| Number of pages | 3 |
| Journal | Pediatric Infectious Disease Journal |
| Volume | 22 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 1 Aug 2003 |
| Externally published | Yes |
Keywords
- Hepatitis B
- Immunity transfer
- Lamivudine
- Marrow transplantation
Fingerprint
Dive into the research topics of 'Durable clearance of hepatitis B virus after allogeneic blood stem cell transplantation by adoptive immunity transfer and antiviral chemotherapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver